Literature DB >> 14970216

Proteasomal degradation of the nuclear targeting growth factor midkine.

Noriyuki Suzuki1, Yoshihisa Shibata, Takeshi Urano, Toyoaki Murohara, Takashi Muramatsu, Kenji Kadomatsu.   

Abstract

It is widely held that growth factor signaling is terminated by lysosomal degradation of its activated receptor and the endocytosed growth factor is transported to lysosomes. Nuclear targeting is another important pathway through which signals of growth factors are mediated. However, mechanisms underlying desensitization of nuclear targeting growth factors are poorly understood. Here we report that the nuclear targeting pathway is down-regulated by the proteasome system. Degradation of endocytosed midkine, a heparin-binding growth factor, was suppressed by both proteasome and lysosome inhibitors to similar extents. By contrast, a proteasome inhibitor, but not lysosome ones, accelerated the nuclear accumulation of midkine. An expression vector of signal sequence-less midkine, which is produced in the cytosol, was constructed because endocytosed midkine may be translocated to the cytosol from cellular compartments before entering the nucleus. The cytosol-produced midkine underwent proteasomal degradation and accumulated in the nucleus as did the endocytosed midkine. It was polyubiquitinated, and its nuclear accumulation was enhanced by a proteasome inhibitor. We further dissected the midkine molecule to investigate roles in degradation and trafficking. The N-terminal half-domain of midkine was significantly more susceptible to proteasomal degradation, whereas the C-terminal half-domain was sufficient for nuclear localization. Together, these data highlight the desensitization of nuclear targeting by growth factors and indicate a critical role of the proteasome system in it.

Mesh:

Substances:

Year:  2004        PMID: 14970216     DOI: 10.1074/jbc.M310772200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Construction of a fusion protein expression vector MK-EGFP and its subcellular localization in different carcinoma cell lines.

Authors:  Li-Cheng Dai; Di-Yong Xu; Xing Yao; Li-Shan Min; Ning Zhao; Bo-Ying Xu; Zheng-Ping Xu; Yong-Liang Lu
Journal:  World J Gastroenterol       Date:  2006-12-21       Impact factor: 5.742

2.  H. sinensis mycelium inhibits epithelial-mesenchymal transition by inactivating the midkine pathway in pulmonary fibrosis.

Authors:  Li Lu; Haiyan Zhu; Hailin Wang; Huaping Liang; Yayi Hou; Huan Dou
Journal:  Front Med       Date:  2021-04-27       Impact factor: 4.592

3.  An essential role for the Glut1 PDZ-binding motif in growth factor regulation of Glut1 degradation and trafficking.

Authors:  Heather L Wieman; Sarah R Horn; Sarah R Jacobs; Brian J Altman; Sally Kornbluth; Jeffrey C Rathmell
Journal:  Biochem J       Date:  2009-03-01       Impact factor: 3.857

Review 4.  Midkine translocated to nucleoli and involved in carcinogenesis.

Authors:  Li-Cheng Dai
Journal:  World J Gastroenterol       Date:  2009-01-28       Impact factor: 5.742

5.  Midkine noncanonically suppresses AMPK activation through disrupting the LKB1-STRAD-Mo25 complex.

Authors:  Tian Xia; Di Chen; Xiaolong Liu; Huan Qi; Wen Wang; Huan Chen; Ting Ling; Wuxiyar Otkur; Chen-Song Zhang; Jongchan Kim; Sheng-Cai Lin; Hai-Long Piao
Journal:  Cell Death Dis       Date:  2022-04-29       Impact factor: 9.685

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.